| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
19,187 |
17,080 |
$5.72M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
25,537 |
22,992 |
$5.16M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
7,197 |
6,559 |
$1.15M |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
28,040 |
24,368 |
$740K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
28,057 |
24,383 |
$729K |
| 80053 |
Comprehensive metabolic panel |
70,002 |
61,570 |
$612K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
79,112 |
67,263 |
$593K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
9,972 |
7,125 |
$581K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
16,376 |
14,888 |
$494K |
| 80061 |
Lipid panel |
36,029 |
32,808 |
$489K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,081 |
10,646 |
$452K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
17,498 |
15,087 |
$440K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,091 |
950 |
$403K |
| 84443 |
Thyroid stimulating hormone (TSH) |
23,613 |
21,061 |
$375K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
5,837 |
5,168 |
$327K |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
12,127 |
10,635 |
$325K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27,877 |
25,402 |
$273K |
| 36415 |
Collection of venous blood by venipuncture |
114,822 |
95,817 |
$260K |
| 86780 |
|
17,079 |
14,649 |
$243K |
| 86803 |
|
15,900 |
13,998 |
$242K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
8,879 |
7,775 |
$220K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
4,450 |
3,284 |
$202K |
| 82728 |
|
13,786 |
12,366 |
$200K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
9,512 |
6,852 |
$188K |
| 80050 |
General health panel |
16,156 |
14,824 |
$177K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
18,686 |
16,243 |
$165K |
| 85027 |
|
23,920 |
20,950 |
$163K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
8,483 |
6,940 |
$147K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,098 |
1,025 |
$146K |
| 82607 |
|
8,793 |
7,982 |
$139K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
1,105 |
726 |
$137K |
| J3490 |
Unclassified drugs |
29,843 |
10,656 |
$135K |
| 84439 |
|
13,799 |
12,450 |
$131K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
1,931 |
1,554 |
$130K |
| 71046 |
Radiologic examination, chest; 2 views |
2,649 |
2,345 |
$119K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
4,935 |
4,393 |
$108K |
| 86480 |
|
1,484 |
1,331 |
$106K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,560 |
1,381 |
$100K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
11,565 |
10,150 |
$94K |
| 83550 |
|
9,468 |
8,620 |
$91K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,443 |
1,215 |
$82K |
| 87340 |
|
8,535 |
7,385 |
$81K |
| 83880 |
|
2,410 |
2,161 |
$81K |
| 80074 |
|
1,655 |
1,452 |
$80K |
| 86762 |
|
4,863 |
4,195 |
$76K |
| 83540 |
|
10,209 |
9,303 |
$73K |
| 86003 |
|
13,116 |
1,460 |
$71K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
74 |
70 |
$69K |
| 83655 |
|
5,416 |
4,794 |
$69K |
| 87077 |
|
8,082 |
6,744 |
$69K |
| 81001 |
|
20,676 |
18,321 |
$68K |
| 86850 |
|
5,492 |
4,652 |
$64K |
| 81513 |
|
9,349 |
7,760 |
$63K |
| 86787 |
|
4,460 |
3,782 |
$62K |
| 84403 |
|
2,135 |
1,902 |
$60K |
| 83516 |
|
5,227 |
4,105 |
$59K |
| 87081 |
|
8,414 |
7,522 |
$57K |
| 83970 |
|
1,633 |
1,471 |
$56K |
| 82570 |
|
9,624 |
8,414 |
$51K |
| 82746 |
|
3,318 |
3,031 |
$51K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
1,904 |
1,388 |
$48K |
| 87186 |
|
5,222 |
4,479 |
$47K |
| 84481 |
|
2,407 |
2,168 |
$45K |
| 84153 |
|
2,339 |
2,164 |
$42K |
| 83001 |
|
2,040 |
1,819 |
$41K |
| 84146 |
|
1,884 |
1,667 |
$40K |
| 83735 |
|
5,981 |
4,890 |
$39K |
| 84402 |
|
1,311 |
1,171 |
$37K |
| 82670 |
|
1,470 |
1,241 |
$37K |
| 82652 |
|
1,068 |
953 |
$32K |
| 86140 |
|
5,776 |
5,089 |
$32K |
| 82950 |
|
6,202 |
5,383 |
$32K |
| 83690 |
|
4,404 |
3,852 |
$32K |
| 82043 |
|
5,492 |
5,089 |
$32K |
| 84702 |
|
3,336 |
2,399 |
$31K |
| 87150 |
|
850 |
801 |
$31K |
| 81025 |
|
3,631 |
3,193 |
$30K |
| 80076 |
|
3,591 |
3,159 |
$30K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
2,191 |
1,747 |
$26K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
760 |
589 |
$26K |
| 82784 |
|
2,766 |
1,954 |
$26K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
567 |
545 |
$26K |
| 87522 |
Neg quan hep c or qual rna |
634 |
569 |
$22K |
| 86696 |
|
1,050 |
889 |
$21K |
| 82951 |
|
1,273 |
1,083 |
$19K |
| 87070 |
|
1,904 |
1,730 |
$18K |
| 83002 |
|
856 |
755 |
$18K |
| 87536 |
|
413 |
375 |
$18K |
| 82105 |
|
984 |
886 |
$17K |
| 86039 |
|
1,700 |
1,491 |
$17K |
| 84484 |
|
1,941 |
1,483 |
$16K |
| 86360 |
|
349 |
317 |
$16K |
| 86901 |
|
5,238 |
4,383 |
$16K |
| 84156 |
|
4,085 |
3,273 |
$16K |
| 86900 |
|
5,192 |
4,382 |
$16K |
| 86376 |
|
1,046 |
903 |
$16K |
| 86706 |
|
1,451 |
1,289 |
$16K |
| 81220 |
CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants |
154 |
134 |
$16K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
255 |
247 |
$16K |
| 85610 |
|
3,839 |
2,925 |
$14K |
| 86359 |
|
372 |
340 |
$14K |
| 84425 |
|
780 |
701 |
$14K |
| 82247 |
|
2,463 |
1,347 |
$14K |
| 86695 |
|
1,051 |
890 |
$14K |
| 82565 |
|
1,887 |
1,532 |
$11K |
| 84480 |
|
714 |
677 |
$11K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
672 |
615 |
$11K |
| 84460 |
|
2,754 |
2,294 |
$10K |
| 84450 |
|
2,576 |
2,122 |
$10K |
| 84144 |
|
467 |
364 |
$10K |
| 87205 |
|
2,010 |
1,793 |
$9K |
| 83615 |
|
1,673 |
1,312 |
$9K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
245 |
225 |
$9K |
| 84550 |
|
2,553 |
2,171 |
$9K |
| 82248 |
|
2,153 |
1,486 |
$9K |
| 85651 |
|
2,455 |
2,112 |
$9K |
| 83020 |
|
672 |
612 |
$9K |
| 82533 |
|
385 |
315 |
$8K |
| 86704 |
|
621 |
581 |
$8K |
| 86431 |
|
1,348 |
1,178 |
$8K |
| 86255 |
|
483 |
384 |
$8K |
| 84630 |
|
801 |
717 |
$8K |
| 84446 |
|
660 |
594 |
$8K |
| 83525 |
|
634 |
505 |
$8K |
| 82525 |
|
705 |
634 |
$7K |
| 84590 |
|
731 |
663 |
$7K |
| 85045 |
|
1,571 |
1,354 |
$7K |
| 84597 |
|
626 |
562 |
$7K |
| 88142 |
|
331 |
298 |
$7K |
| 82977 |
|
1,178 |
977 |
$6K |
| 82627 |
|
291 |
249 |
$6K |
| 87210 |
|
2,984 |
2,758 |
$6K |
| 86235 |
|
195 |
161 |
$5K |
| 86038 |
|
408 |
383 |
$5K |
| 85652 |
|
2,158 |
1,938 |
$5K |
| 84100 |
|
1,583 |
1,177 |
$5K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
14 |
12 |
$5K |
| 85730 |
|
820 |
730 |
$5K |
| 82952 |
|
1,031 |
859 |
$5K |
| J7050 |
Infusion, normal saline solution, 250 cc |
617 |
201 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
137 |
106 |
$4K |
| 86225 |
|
241 |
222 |
$4K |
| 83993 |
|
134 |
130 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,143 |
1,016 |
$4K |
| 82465 |
|
542 |
499 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
28 |
26 |
$3K |
| 87507 |
|
16 |
14 |
$3K |
| 82550 |
|
461 |
392 |
$3K |
| 86708 |
|
223 |
195 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
282 |
156 |
$3K |
| 86200 |
|
159 |
150 |
$3K |
| 36416 |
|
2,425 |
1,472 |
$3K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
226 |
207 |
$2K |
| 86800 |
|
117 |
107 |
$2K |
| 81511 |
|
1,480 |
1,265 |
$2K |
| 85018 |
|
828 |
764 |
$2K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
703 |
558 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
198 |
179 |
$2K |
| 86160 |
|
148 |
117 |
$2K |
| 87529 |
|
56 |
53 |
$2K |
| 81329 |
|
106 |
81 |
$2K |
| 80197 |
|
174 |
113 |
$2K |
| 80069 |
|
226 |
182 |
$2K |
| 87449 |
|
123 |
110 |
$2K |
| 0097U |
|
36 |
25 |
$1K |
| 82150 |
|
162 |
153 |
$1K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
14 |
13 |
$1K |
| 80164 |
|
98 |
92 |
$1K |
| 87209 |
|
45 |
39 |
$1K |
| 82785 |
|
55 |
51 |
$1K |
| 83021 |
|
107 |
76 |
$984.41 |
| 83520 |
|
66 |
53 |
$890.88 |
| 85660 |
|
145 |
128 |
$813.32 |
| 85014 |
|
429 |
402 |
$779.83 |
| 83519 |
|
54 |
40 |
$779.47 |
| 82103 |
|
44 |
43 |
$755.98 |
| 87338 |
|
57 |
54 |
$741.23 |
| 87075 |
|
65 |
55 |
$638.90 |
| 83498 |
|
14 |
14 |
$622.89 |
| J2704 |
Injection, propofol, 10 mg |
107 |
94 |
$564.64 |
| 87177 |
|
45 |
39 |
$530.44 |
| 87324 |
|
89 |
80 |
$529.86 |
| C1769 |
Guide wire |
14 |
13 |
$521.60 |
| 86677 |
|
26 |
25 |
$515.22 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
29 |
25 |
$484.33 |
| 87563 |
|
17 |
16 |
$467.40 |
| 82310 |
|
66 |
58 |
$382.38 |
| 82390 |
|
28 |
26 |
$378.27 |
| 83721 |
|
430 |
409 |
$357.07 |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
14 |
13 |
$344.43 |
| 86592 |
|
76 |
69 |
$337.90 |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
12 |
12 |
$298.20 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
14 |
13 |
$285.01 |
| 84132 |
|
44 |
43 |
$247.10 |
| 83701 |
|
13 |
13 |
$226.40 |
| 82947 |
|
52 |
51 |
$221.58 |
| C1760 |
Closure device, vascular (implantable/insertable) |
12 |
12 |
$194.56 |
| 80177 |
|
12 |
12 |
$175.09 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
35 |
26 |
$159.92 |
| 84478 |
|
112 |
87 |
$147.11 |
| 83718 |
|
12 |
12 |
$128.52 |
| J1010 |
Injection, methylprednisolone acetate, 1 mg |
22 |
12 |
$84.48 |
| 87147 |
|
14 |
13 |
$83.85 |
| J0665 |
Injection, bupivicaine, not otherwise specified, 0.5 mg |
73 |
39 |
$64.67 |
| 82040 |
|
13 |
12 |
$60.10 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
17 |
14 |
$46.17 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
13 |
12 |
$44.05 |
| 84436 |
|
12 |
12 |
$42.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
27 |
26 |
$31.52 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
29 |
26 |
$25.98 |
| Q9965 |
Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml |
23 |
13 |
$14.52 |
| J1644 |
Injection, heparin sodium, per 1000 units |
17 |
12 |
$9.66 |
| 81005 |
|
12 |
12 |
$5.40 |
| 84520 |
|
14 |
12 |
$0.00 |
| 80304 |
|
37 |
37 |
$0.00 |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
19 |
12 |
$0.00 |